Oxidative stress in rat retina and hippocampus after chronic MDMA ('ecstasy') administration

Neurochemical Research

Volumn 32, Issue 7, 2007, Pages 1156-1162

  Miranda, María ^a,b   Bosch Morell, Francisco ^a,b   Johnsen Soriano, Siv ^a,b   Barcia, Jorge ^a   Almansa, Inmaculada ^a   Asensio, Samuel ^a   Araiz, Javier ^c   Messeguer, Angel ^d   Romero, Francisco J ^a,b  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b Fundacion Oftalmologica del Mediterraneo   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

Antioxidant; Apoptosis; CR6; MDMA; Nervous tissue; Oxidative stress

Indexed keywords

3,4 DIHYDRO 6 HYDROXY 7 METHOXY 2,2 DIMETHYL 1 BENZOPYRAN; 3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ANTIOXIDANT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN; CELL NUCLEUS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; LIVER; MALE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETINA; RETINA CELL;

ANIMALS; BENZOPYRANS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIPPOCAMPUS; HUMANS; IN SITU NICK-END LABELING; LIVER; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RATS, WISTAR; RETINA; SEROTONIN AGENTS;

RATTUS;

EID: 34249300166     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9285-1     Document Type: Article

References (37)

1. Saunders N (1995) In: Ecstasy and the dance culture. Nicholas Saunders, London
2. Robbins TW, Everitt BJ (1999) Drug addiction: bad habits add up. Nature 398:567-570
3. Reneman L (2003) Designer drugs: how dangerous are they? J Neural Transm 66:61-83
4. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1-7
5. Battaglia SY, De Souza EB (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269-274
6. Kalant H (2001) The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 165:7
7. Beitia G, Cobreros A, Sainz L et al (2000) Ecstasy-induced toxicity in rat liver. Liver 20:8-15
8. Gudelsky GA, Yamamoto BK (2003) Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Methods Mol Med 79:55-73
9. Zhou JF, Zhou YH, Zhang L et al (2003) 3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage. Biomed Environ Sci 16:53-61
10. Cadet JL, Thiriet N, Jayanthi S (2001) Involvement of free radicals in MDMA-induced neurotoxicity in mice. Ann Med Interne 152:57-59
11. Colado MI, ÓShea E, Granados R et al (1997) In vivo evidence for free radical involvement in 5-HT following administration of MDMA ("ecstasy") and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol 121:889-900
12. Gudelsky GA (1996) Effect of ascorbate and cysteine on the 3,4-methyl-enedioxymethamphetamine-induced depletion of brain serotonin. J Neural Transm 102:1397-1404
13. Shankaran M, Yamamoto BK, Gudelski GA (2001) Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of the brain. Synapse 40:55-64
14. Aguirre N, Barrionuevo M, Ramírez MJ et al (1999). Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity. Neuroreport 10:3675-3680
15. Clauwaert KM, Van Bocxlaer JF, De Letter EA et al (2000) Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4- methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine. Clin Chem 46:1968-1977
16. Irurre J, Casas J, Ramos I et al (1993) Inhibition of rat liver microsomal lipid peroxidation elicited by 2,2-dimethylchromenes and chromans containing fluorinated moieties resistant to cytochrome P-450 metabolism. Bioorg Med Chem 1:219-225
17. Montoliu C, Llansola M, Sáez R et al (1999) Prevention of glutamate neurotoxicity in cultured neuronas by 3,4-dihydro-6-hydroxy-7-methoxy- 2,2-dimethyl-1(2H)-benzopyran (CR-6), a sacvenger of nitric oxide. Biochem Pharmacol 58:255-261
18. Jimenez A, Jorda EG, Verdaguer E et al (2004) Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol Appl Pharmacol 196:223-234
19. Montiel-Duarte C, Ansorena E, Lopez-Zabalza MJ et al (2004) Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine ("Ecstasy") on hepatic stellate cells. Biochem Pharmacol 67:1025-1033
20. Simantov R, Tauber M (1997) The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells. FASEB J 11:141-146
21. Casas J, Gorchs G, Sanchez-Baeza F et al (1992) Inhibition of rat liver microsomal lipid peroxidation elicited by simple 2,2-dimethylchromenes and chromans structurally related to precocenes. J Agric Food Chem 40:585-590
22. Richard MJ, Guiraud P, Meo J et al (1992) High performance liquid chromatography separation of malondialdehyde thiobarbituric acid adduct in biological materials (plasma and human cell) using a comercially available reagent. J Chromatogr 577:9-18
23. Romero MJ, Bosch-Morell F, Romero B et al (1998) Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients. Free Radical Biol Med 25:993-997
24. Lawrence RA, Parkhill LK, Burk RF (1978) Hepatic cytosolic non-selenium dependent glutathione peroxidase activity: its nature and the effect of selenium deficiency. J Nutr 108:981-987
25. Reed DJ, Babson JR, Beatty PW et al (1980) High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal Biochem 106:55-62
26. Lowry OH, Rosebrough NJ, Farr AL et al (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
27. Doly M, Droy-Lefaix MT, Braquet P (1992) Oxidative stress in diabetic retina. EXS62:299-307
28. Carvalho M, Milhazes N, Remiao F et al (2004) Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch Toxicol 78:16-24
29. Colado MI, Camarero J, Mecham AO et al (2001) A study of the mechanisms involved in the neurotoxic action of 3,4-methylendioxymethamphetamine (MDMA, "ecstasy") on dopamine neurones in mouse brains. Br J Pharmacol 134:1711-1723
30. Jayanthi S, Ladenheim B, Andrews AM et al (1999) Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphethamine (Ecstasy). Neuroscience 91:1379-1387
31. Camarero J, Sanchez V, O'Shea E et al (2002) Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum. J Neurochem 81:961-972
32. Gastinger MJ, Singh RS, Barber AJ (2006) Loss of Cholinergic and Dopaminergic Amacrine Cells in Streptozotocin-Diabetic Rat and Ins2Akita-Diabetic Mouse Retinas. Invest Ophthalmol Vis Sci 47:3143-3150
33. Takita H, Yoneya S, Gehlbach PL et al (2003) Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44:4497-4504
34. Jacobsen LK, Mencl WE, Pugh KR et al (2004) Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects. Psychopharmacology 173:383-390
35. Huether G, Zhou D, Ruther E (1997) Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4- methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners. J Neural Transm 104:771-794
36. Parrott AC (2001) Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 16:557-577
37. Sanvicens N, Gómez-Vicente V, Masip I et al (2004) Oxidative stress-induced apoptosis in retinal photoreceptor cells is mediated by calpains and caspases and blocked by the oxygen radical scavenger CR-6. J Biol Chem 279:39268-39278